Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 31;7(4):54.
doi: 10.3390/tropicalmed7040054.

Immune Responses in Leishmaniasis: An Overview

Affiliations
Review

Immune Responses in Leishmaniasis: An Overview

Ana Caroline Costa-da-Silva et al. Trop Med Infect Dis. .

Abstract

Leishmaniasis is a parasitic, widespread, and neglected disease that affects more than 90 countries in the world. More than 20 Leishmania species cause different forms of leishmaniasis that range in severity from cutaneous lesions to systemic infection. The diversity of leishmaniasis forms is due to the species of parasite, vector, environmental and social factors, genetic background, nutritional status, as well as immunocompetence of the host. Here, we discuss the role of the immune system, its molecules, and responses in the establishment, development, and outcome of Leishmaniasis, focusing on innate immune cells and Leishmania major interactions.

Keywords: immunology; immunomodulation; immunoparasitology; infection; leishmaniasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Impact of Leishmania infection on immune cells. Leishmania spp. interacts with multiple innate immune cells modulating their phenotype and function, as well as the adaptive immune responses. Mast cells collaborate in disease progression by secreting IL-4 and IL-13 fostering Th2 responses and parasite survival (panel 1). Neutrophils, macrophages, and DCs can either eliminate or promote parasite survival. Recruited neutrophils eliminate leishmanial parasites through phagocytosis, ROS, and NETs release. Leishmania can survive transiently within neutrophils by inhibiting phagolysosome biogenesis and oxidative stress, and by delaying neutrophil apoptosis. Infected neutrophils also secrete IL-8 and MIP1β, which attract additional neutrophils and other phagocytic cells, favoring Leishmania survival and pathology (panel 2). Macrophages can be differentiated in M1 or M2 during leishmaniasis. M1 macrophages produce proinflammatory cytokine and chemokines, NO and ROS, booster Th1 responses, and favor disease control. M2 macrophages increase the production of IL-10 and TGFβ, and support Th2 response and disease progression (panel 3). DCs regulate immune responses against Leishmania by migrating to the draining lymph nodes to present Leishmania-derived antigen to naïve T cells. DCs can induce the differentiation of Th1 by secreting IL-12 and IL-27 or Th2, by blocking IL-12 secretion (panel 4). NK cells have a protective role in leishmaniasis by secreting IFNγ to boost Th1 response (panel 5). IL; interleukin IFNγ; ROS; reactive oxidative species, NO; nitric oxide, NETs; neutrophil extracellular traps, MIP; macrophage; inflammatory protein, TNFα; tumor necrosis factor α, TGFβ; transforming growth factor-β, NK; natural killer.

References

    1. Choi H.L., Jain S., Ruiz Postigo J.A., Borisch B., Dagne D.A. The global procurement landscape of leishmaniasis medicines. PLoS Negl. Trop. Dis. 2021;15:e0009181. doi: 10.1371/journal.pntd.0009181. - DOI - PMC - PubMed
    1. Benallal K.E., Garni R., Harrat Z., Volf P., Dvorak V. Phlebotomine sand flies (Diptera: Psychodidae) of the Maghreb region: A systematic review of distribution, morphology, and role in the transmission of the pathogens. PLoS Negl. Trop. Dis. 2022;16:e0009952. doi: 10.1371/journal.pntd.0009952. - DOI - PMC - PubMed
    1. Daga M.K., Rohatgi I., Mishra R. Leishmaniasis. Indian J. Crit. Care Med. 2021;25:S166–S170. doi: 10.5005/jp-journals-10071-23844. - DOI - PMC - PubMed
    1. Goto H., Lauletta Lindoso J.A. Cutaneous and mucocutaneous leishmaniasis. Infect. Dis. Clin. N. Am. 2012;26:293–307. doi: 10.1016/j.idc.2012.03.001. - DOI - PubMed
    1. Van Assche T., Deschacht M., da Luz R.A., Maes L., Cos P. Leishmania-macrophage interactions: Insights into the redox biology. Free Radic. Biol. Med. 2011;51:337–351. doi: 10.1016/j.freeradbiomed.2011.05.011. - DOI - PubMed

LinkOut - more resources